Primary Site >> Liver Cancer
Gene >> NAMPT
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells. PMID: 21952585 |
Ref: Adipocytokines and hepatocellular carcinoma. PMID: 23108307 |
Ref: Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan. PMID: 24895413 Ref: Role of adipokines and cytokines in non-alcoholic fatty liver disease. PMID: 25514909 |
Ref: FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells. PMID: 25656579 Ref: Secretion of one adipokine Nampt/Visfatin suppresses the inflammatory stress-induced NF-kappaB activity and affects Nampt-dependent cell viability in Huh-7 cells. PMID: 25814788 |
Ref: Genetic variant in visfatin gene promoter contributes to reduced risk of hepatocellular carcinoma in a Chinese population. PMID: 27792999 |
Ref: Circulating visfatin level is associated with hepatocellular carcinoma in chronic hepatitis B or C virus infection. PMID: 27770715 Ref: Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma. PMID: 28178643 Ref: Could NAMPT inhibition become a potential treatment option in hepatocellular carcinoma? PMID: 28271737 |
Ref: Visfatin increases miR-21 to promote migration in HCC. PMID: 29808800 |